Anti-Candida activity of essential oils

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 11, 2009, Pages 1292-1305

  Palmeira de Oliveira, A ^a   Salgueiro, L ^b   Palmeira de Oliveira, R ^a   Martinez de Oliveira, J ^a,c   Pina Vaz, C ^d   Queiroz, J A ^a   Rodrigues, A G ^d  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Hospital Center Cova da Beira   (Portugal)

^d University of Porto   (Portugal)

Author keywords

Anti Candida activity; Candidosis; Chemical composition; Essential oils; In vitro studies; In vivo studies; Mechanism of action; Therapeutic association

Indexed keywords

ALCOHOL; ALDEHYDE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BETA PHELLANDRENE; BETA PINENE; CARVACROL; CINEOLE; CITRAL; CLOVE OIL; ESSENTIAL OIL; ETHER; EUGENOL; GERANIUM OIL; HYDROCARBON; KETOCONAZOLE; KETONE DERIVATIVE; LINALOOL; NYSTATIN; PHENOL; PHENYLPROPANOID; TEA TREE OIL; TERPENOID; THYMOL; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGAR DIFFUSION; AGAR DILUTION; ANTICANDIDA ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BROTH DILUTION; CANDIDA ALBICANS; CHEMICAL COMPOSITION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG FORMULATION; DRUG ISOLATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG TOLERABILITY; ENCAPSULATION; HUMAN; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; LOW DRUG DOSE; NONHUMAN; SHORT SURVEY; STOMATITIS; VAGINA CANDIDIASIS; VAPORIZATION;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; HUMANS; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE;

EID: 73349112212     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709789878150     Document Type: Short Survey

References (110)

1. Costa-de-Oliveira, S.; Pina-Vaz, C.; Mendonca, D.; Goncalves Rodrigues, A. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur. J. Clin. Microbiol. Infect. Dis., 2008, 27, 365-74.
2. Hajjeh, R. A.; Sofair, A. N.; Harrison, L. H.; Lyon, G. M.; Arthington-Skaggs, B. A.; Mirza, S. A.; Phelan, M.; Morgan, J.; Lee-Yang, W.; Ciblak, M. A.; Benjamin, L. E.; Sanza, L. T.; Huie, S.; Yeo, S. F.; Brandt, M. E.; Warnock, D. W. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol., 2004, 42, 1519-27.
3. Pauli, A. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med. Res. Rev., 2006, 26, 223-68.
4. Mardh, P. A.; Rodrigues, A. G.; Genc, M.; Novikova, N.; Martinez-de-Oliveira, J.; Guaschino, S. Facts and myths on recurrent vulvovaginal candidosis-a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J. STD. AIDS., 2002, 13, 522-39.
5. Koroch, A.; Juliani, R.; Zygadlo, J. Bioactivity of essential oils and their components. In Flavours and Fragances - chemistry, bioprocessing and sustainability; Springer Press: Berlin, 2007; pp. 87-115.
6. de Oliveira, J. M.; Cruz, A. S.; Fonseca, A. F.; Vaz, C. P.; Rodrigues, A.; Aurea, F.; Maia, J.; Sousa, J. A. Prevalence of Candida albicans in vaginal fluid of asymptomatic Portuguese women. J. Reprod. Med., 1993, 38, 41-2.
7. Mardh, P. A.; Novikova, N.; Stukalova, E. Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis. B.J.O.G., 2003, 110, 934-7.
8. Hajjeh, R. A.; Conn, L. A.; Stephens, D. S.; Baughman, W.; Hamill, R.; Graviss, E.; Pappas, P. G.; Thomas, C.; Reingold, A.; Rothrock, G.; Hutwagner, L. C.; Schuchat, A.; Brandt, M. E.; Pinner, R. W. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virusinfected persons. Cryptococcal Active Surveillance Group. J. Infect. Dis., 1999, 179, 449-54.
9. Sobel, J. D. Vulvovaginal candidosis. Lancet, 2007, 369, 1961-71.
10. Valore, E. V.; Park, C. H.; Igreti, S. L.; Ganz, T. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol., 2002, 187, 561-8.
11. Otero, L.; Palacio, V.; Carreno, F.; Mendez, F. J.; Vazquez, F. Vulvovaginal candidiasis in female sex workers. Int. J. STD. AIDS., 1998, 9, 526-30.
12. Corsello, S.; Spinillo, A.; Osnengo, G.; Penna, C.; Guaschino, S.; Beltrame, A.; Blasi, N.; Festa, A. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 110, 66-72.
13. Geiger, A. M.; Foxman, B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology, 1996, 7, 182-7.
14. El-Din, S.; Reynolds, M.; Ashbee, H.; Barton, R.; Evans, E. An investigation into the pathogenesis of vulvo-vaginal candidosis. Sex. Transm. Infect., 2001, 77, 179-83.
15. Sobel, J. Candida vulvovaginitis. In Vulvovaginal infections; Academy Professional Information Services: New York, 1990; pp. 36-56.
16. Sobel, J.; Muller, G.; Buckley, H. Critical Role of Germ Tube Formation in the Pathogenesis of Candida Vaginitis. Infect. Immun., 1984, 44, 576-80.
17. Rodrigues, A. G.; Mardh, P. A.; Pina-Vaz, C.; Martinez-de-Oliveira, J.; Fonseca, A. F. Germ tube formation changes surface hydrophobicity of Candida cells. Infect. Dis. Obstet. Gynecol., 1999, 7, 222-6.
18. Chandra, J.; Kuhn, D. M.; Mukherjee, P. K.; Hoyer, L. L.; McCormick, T.; Ghannoum, M. A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol., 2001, 183, 5385-94.
19. Douglas, L. J. Candida biofilms and their role in infection. Trends Microbiol., 2003, 11, 30-6.
20. Carrillo-Munoz, A. J.; Giusiano, G.; Ezkurra, P. A.; Quindos, G. Antifungal agents: mode of action in yeast cells. Rev. Esp. Quimioter., 2006, 19, 130-9.
21. Nurbhai, M.; Grimshaw, J.; Watson, M.; Bond, C.; Mollison, J.; Ludbrook, A. Oral versus intra-vaginal imidazole and triazole antifungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev., 2007, CD002845.
22. Van Kessel, K.; Assefi, N.; Marrazzo, J.; Eckert, L. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstet. Gynecol. Surv., 2003, 58, 351-8.
23. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils-a review. Food Chem. Toxicol., 2008, 46, 446-75.
24. Fresno, A. Farmacognosia Generale, Editorial Sintese SA: Madrid, 1999.
25. Mukherjee, P. K. Quality Control of Herbal Drugs. An approach to evaluation of botanicals, Business Horizons: New Delhi, 2002; pp. 287-304.
26. International Organization for Standardisation, Aromatic Natural Raw. In Geneve, Switzerland, 1997.
27. Baser, K.; Demitri, F. Chemistry of essential oils. In Flavours and Fragrances - chemistry, bioprocessing and sustainability; Springer Press: Berlin, 2007; pp. 43-86.
28. Lis-Balchin, M. Aromatherapy Science, Pharmaceutical Press: London, 2009; pp. 31-43.
29. Giordani, R.; Regli, P.; Kaloustian, J.; Mikail, C.; Abou, L.; Portugal, H. Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother. Res., 2004, 18, 990-5.
30. Tampieri, M. P.; Galuppi, R.; Macchioni, F.; Carelle, M. S.; Falcioni, L.; Cioni, P. L.; Morelli, I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia, 2005, 159, 339-45.
31. Bozin, B.; Mimica-Dukic, N.; Samojlik, I.; Jovin, E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J. Agric. Food. Chem., 2007, 55, 7879-85.
32. Rios, J. L.; Recio, M. C.; Villar, A. Screening methods for natural products with antimicrobial activity: a review of the literature. J. Ethnopharmacol., 1988, 23, 127-49.
33. Carson, C. F.; Riley, T. V. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. J. Appl. Bacteriol., 1995, 78, 264-9.
34. Inouye, S.; Tsuruoka, T.; Uchida, K.; Yamaguchi, H. Effect of sealing and Tween 80 on the antifungal susceptibility testing of essential oils. Microbiol. Immunol., 2001, 45, 201-8.
35. Mann, C. M.; Markham, J. L. A new method for determining the minimum inhibitory concentration of essential oils. J. Appl. Microbiol., 1998, 84, 538-44.
36. Scorzoni, L.; Benaducci, T.; Almeida, A.; Silva, D.; Bolzani, V.; Mendes-Giannini, M. Comparative study of disk diffusion and microdilution methods for evaluation of antifungal activity of natural compounds against medical yeasts Candida spp and Cryptococcus sp. Rev. Ciênc. Farm. Básica Apl., 2007, 28, 25-34.
37. Burt, S. Essential oils: their antibacterial properties and potential applications in foods-a review. Int. J. Food Microbiol., 2004, 94, 223-53.
38. CLSI, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition. In CLSI document M27-A3, Clinical and Laboratory Standards Institute: Wayne, PA, 2008.
39. Lopez, P.; Sanchez, C.; Batlle, R.; Nerin, C. Vapor-phase activities of cinnamon, thyme, and oregano essential oils and key constituents against foodborne microorganisms. J. Agric. Food. Chem., 2007, 55, 4348-56.
40. Suhr, K. I.; Nielsen, P. V. Antifungal activity of essential oils evaluated by two different application techniques against rye bread spoilage fungi. J. Appl. Microbiol., 2003, 94, 665-74.
41. Duarte, M. C.; Figueira, G. M.; Sartoratto, A.; Rehder, V. L.; Delarmelina, C. Anti-Candida activity of Brazilian medicinal plants. J. Ethnopharmacol., 2005, 97, 305-11.
42. Hammer, K. A.; Carson, C. F.; Riley, T. V. Antimicrobial activity of essential oils and other plant extracts. J. Appl. Microbiol., 1999, 86, 985-90.
43. Sahin, F. Biological activities of the essential oils and methanol extract of Origanum vulgare spp vulgare in the Eastern Anatolia region of Turkey. Food Control, 2004, 15, 549-557.
44. Hili, P.; Evans, C. S.; Veness, R. G. Antimicrobial action of essential oils: the effect of dimethylsulphoxide on the activity of cinnamon oil. Lett. Appl. Microbiol., 1997, 24, 269-75.
45. Hammer, K. A.; Carson, C. F.; Riley, T. V. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J. Antimicrob. Chemother., 1998, 42, 591-5.
46. Hammer, K. A.; Carson, C. F.; Riley, T. V. Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J. Appl. Microbiol., 2003, 95, 853-60.
47. Pinto, E.; Pina-Vaz, C.; Salgueiro, L.; Goncalves, M. J.; Costa-de-Oliveira, S.; Cavaleiro, C.; Palmeira, A.; Rodrigues, A.; Martinezde-Oliveira, J. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J. Med. Microbiol., 2006, 55, 1367-73.
48. Pina-Vaz, C.; Goncalves Rodrigues, A.; Pinto, E.; Costa-de-Oliveira, S.; Tavares, C.; Salgueiro, L.; Cavaleiro, C.; Goncalves, M. J.; Martinez-de-Oliveira, J. Antifungal activity of Thymus oils and their major compounds. J. Eur. Acad. Dermatol. Venereol., 2004, 18, 73-8.
49. Salgueiro, L. R.; Cavaleiro, C.; Pinto, E.; Pina-Vaz, C.; Rodrigues, A. G.; Palmeira, A.; Tavares, C.; Costa-de-Oliveira, S.; Goncalves, M. J.; Martinez-de-Oliveira, J. Chemical composition and antifungal activity of the essential oil of Origanum virens on Candida species. Planta Med., 2003, 69, 871-4.
50. Salgueiro, L. R.; Pinto, E.; Goncalves, M. J.; Pina-Vaz, C.; Cavaleiro, C.; Rodrigues, A. G.; Palmeira, A.; Tavares, C.; Costa-de-Oliveira, S.; Martinez-de-Oliveira, J. Chemical composition and antifungal activity of the essential oil of Thymbra capitata. Planta Med., 2004, 70, 572-5.
51. Shin, S.; Pyun, M. S. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B. Phytother. Res., 2004, 18, 827-30.
52. Manohar, V.; Ingram, C.; Gray, J.; Talpur, N. A.; Echard, B. W.; Bagchi, D.; Preuss, H. G. Antifungal activities of origanum oil against Candida albicans. Mol. Cell Biochem., 2001, 228, 111-7.
53. da Silva Cde, B.; Guterres, S. S.; Weisheimer, V.; Schapoval, E. E. Antifungal activity of the lemongrass oil and citral against Candida spp. Braz. J. Infect. Dis., 2008, 12, 63-6.
54. Hammer, K. A.; Carson, C. F.; Riley, T. V. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J. Antimicrob. Chemother., 2004, 53, 1081-5.
55. Ahmad, N.; Alam, M. K.; Shehbaz, A.; Khan, A.; Mannan, A.; Hakim, S. R.; Bisht, D.; Owais, M. Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis. J. Drug Target, 2005, 13, 555-61.
56. Oliva, B.; Piccirilli, E.; Ceddia, T.; Pontieri, E.; Aureli, P.; Ferrini, A. M. Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Lett. Appl. Microbiol., 2003, 37, 185-7.
57. Gonçalves, M. J.; Vicente, A. M.; Cavaleiro, C.; Salgueiro, L. Composition and antifungal activity of the essential oil of Mentha cervina from Portugal. Nat. Prod. Res., 2007, 21, 867-71.
58. He, M.; Du, M.; Fan, M.; Bian, Z. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia, 2007, 163, 137-43.
59. Braga, P. C.; Alfieri, M.; Culici, M.; Dal Sasso, M. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses, 2007, 50, 502-6.
60. Cosentino, S.; Tuberoso, C. I.; Pisano, B.; Satta, M.; Mascia, V.; Arzedi, E.; Palmas, F. In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett. Appl. Microbiol., 1999, 29, 130-5.
61. Cox, S. D.; Mann, C. M.; Markham, J. L.; Bell, H. C.; Gustafson, J. E.; Warmington, J. R.; Wyllie, S. G. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J. Appl. Microbiol., 2000, 88, 170-5.
62. Bagg, J.; Jackson, M. S.; Petrina Sweeney, M.; Ramage, G.; Davies, A. N. Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer. Oral Oncol., 2006, 42, 487-92.
63. Braga, P. C.; Culici, M.; Alfieri, M.; Dal Sasso, M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int. J. Antimicrob. Agents, 2008, 31, 472-7.
64. Salgueiro, L.; Pinto, E.; Gonçalves, M. J.; Costa, I.; Palmeira, A.; Cavaleiro, C.; Pina-Vaz, C.; Rodrigues, A. G.; Martinez-de-Oliveira, A. Antifungal activity of the essential oil of Thymus capitellatus against Candida, Aspergillus and dermatophyte strains. Flavour Fragr. J., 2006, 21, 749-53.
65. Farag, R. S.; Shalaby, A. S.; El-Baroty, G. A.; Ibrahim, N. A.; Ali, M. A.; Hassan, E. M. Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytother. Res., 2004, 18, 30-5.
66. Mondello, F.; De Bernardis, F.; Girolamo, A.; Cassone, A.; Salvatore, G. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azolesusceptible and -resistant human pathogenic Candida species. BMC Infect. Dis., 2006, 6, 158.
67. Carson, C. F.; Hammer, K. A.; Riley, T. V. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin. Microbiol. Rev., 2006, 19, 50-62.
68. Agarwa, V.; Lal, P.; Pruthi, V. Prevention of Candida albicans biofilm by plant oils. Mycopathologia, 2008, 165, 13-19.
69. International Organization for Standardisation, Oil of Melaleuca, terpinen-4-ol type (tea tree oil). In ISO 4730:2004, Geneve, Switzerland, 2004.
70. Carson, C. F.; Riley, T. V. Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Contact. Dermatitis, 2001, 45, 65-7.
71. MacKay, D. L.; Blumberg, J. B. A Review of the Bioactivity and Potential Health Benefits of Peppermint Tea (Mentha piperita L.). Phytother. Res., 2006, 20, 619-33.
72. Tavares, C. B.; Pina-Vaz, C.; Rodrigues, A. G.; Costa-de-Oliveira, S.; Pinto, E.; Salgueiro, L.; Cavaleiro, C.; Gonçalves, M. J.; Palmeira, A.; Martinez-de-Oliveira, J. The fungicidal activity of eugenol on Candida spp results from a primary lesion of the cell membrane. Clin. Microbiol. Infect., 2003, 9, 89.
73. Devkatte, A. N.; Zore, G. B.; Karuppayil, S. M. Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeasts Res., 2005, 5, 867-873.
74. Maudsley, F.; Kerr, K. G. Microbiological safety of essential oils used in complementary therapies and the activity of these compounds against bacterial and fungal pathogens. Support Care Cancer, 1999, 7, 100-2.
75. Pinto, E.; Salgueiro, L. R.; Cavaleiro, C.; Palmeira, A.; Gonçalves, M. J. In vitro susceptibility of some species of yeasts and filamentous fungi to essential oils of Salvia officinalis. Ind. Crop. Prod., 2007, 26, 135-141.
76. Dorman, H. J.; Deans, S. G. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J. Appl. Microbiol., 2000, 88, 308-16.
77. Evans, W. Pharmacognosy, 15th ed.; Saunders: London, 2002.
78. Kurita, N.; Miyaji, M.; Kurane, R.; Takahara, Y. Antifungal Activity of Components of Essential Oils. Agric. Biol. Chem., 1981, 45, 945-952.
79. Cox, S. D.; Mann, C. M.; Markham, J. L. Interactions between components of the essential oil of Melaleuca alternifolia. J. Appl. Microbiol., 2001, 91, 492-7.
80. Hornby, J. M.; Jensen, E. C.; Lisec, A. D.; Tasto, J. J.; Jahnke, B.; Shoemaker, R.; Dussault, P.; Nickerson, K. W. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol., 2001, 67, 2982-92.
81. Silvestre, A.; Cavaleiro, J.; Feio, S.; Roseiro, J.; Delmond, B.; Filliatre, C. Synthesis of Some New Benzylic Ethers from 1,8-Cineole with Antimicrobial Activity. Monatshefte fur Chemie, 1999, 130, 589-595.
82. Lambert, R. J.; Skandamis, P. N.; Coote, P. J.; Nychas, G. J. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microbiol., 2001, 91, 453-62.
83. Sanchez, M. E.; Turina, A. V.; Garcia, D. A.; Nolan, M. V.; Perillo, M. A. Surface activity of thymol: implications for an eventual pharmacological activity. Colloids Surf. B. Biointerfaces, 2004, 34, 77-86.
84. Bennis, S.; Chami, F.; Chami, N.; Bouchikhi, T.; Remmal, A. Surface alteration of Saccharomyces cerevisiae induced by thymol and eugenol. Lett. Appl. Microbiol., 2004, 38, 454-8.
85. Hammer, K. A.; Carson, C. F.; Riley, T. V. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med. Mycol., 2000, 38, 355-62.
86. Espinel-Ingroff, A. Antifungal agents, 2nd ed.; Academic Press: London, 2000.
87. Nzeako, B.; Bushra, A. Comparative studies of antimicotic potential of thyme and clove oil extracts with antifungal antibiotics on Candida albicans. Afr. J. Biotechnol., 2008, 7, 1612-19.
88. Giordani, R.; Regli, P.; Kaloustian, J.; Portugal, H. Potentiation of antifungal activity of amphotericin B by essential oil from Cinnamomum cassia. Phytother. Res., 2006, 20, 58-61.
89. Hemaiswarya, S.; Kruthiventi, A. K.; Doble, M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine, 2008, 15, 639-52.
90. Sun, S.; Gao, Y.; Ling, X.; Lou, H. The combination effects of phenolic compounds and fluconazole on the formation of ergosterol in Candida albicans determined by high-performance liquid chromatography/ tandem mass spectrometry. Anal. Biochem., 2005, 336, 39-45.
91. Rosato, A.; Vitali, C.; Gallo, D.; Balenzano, L.; Mallamaci, R. The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. Phytomedicine, 2008, 15, 635-38.
92. Buckle, J. Essential oils: Management and treatment of gynecologic infections and stressors. Sexuality Reproduction and Menopause. Sexuality Reproduction and Menopause, 2006, 4, 38-41.
93. Chami, N.; Chami, F.; Bennis, S.; Trouillas, J.; Remmal, A. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz. J. Infect. Dis., 2004, 8, 217-26.
94. Chami, F.; Chami, N.; Bennis, S.; Trouillas, J.; Remmal, A. Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. J. Antimicrob. Chemother., 2004, 54, 909-14.
95. Maruyama, N.; Takizawa, T.; Ishibashi, H.; Hisajima, T.; Inouye, S.; Yamaguchi, H.; Abe, S. Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice. Biol. Pharm. Bull., 2008, 31, 1501-6.
96. Mondello, F.; De Bernardis, F.; Girolamo, A.; Salvatore, G.; Cassone, A. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J. Antimicrob. Chemother., 2003, 51, 1223-9.
97. Belaiche, P. Traitement des infections vaginales a Candida albicans par l'huile essentielle de Melaleuca alternifolia. Phytotherapie, 1985, 153, 455-458.
98. Hammer, K. A.; Carson, C. F.; Riley, T. V. Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am. J. Infect. Control., 1996, 24, 186-9.
99. Jandourek, A.; Vaishampayan, J. K.; Vazquez, J. A. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS, 1998, 12, 1033-7.
100. Vazquez, J. A.; Zawawi, A. A. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazolerefractory oropharyngeal candidiasis in patients with AIDS. HIV Clin. Trials., 2002, 3, 379-85.
101. Catalan, A.; Pacheco, J. G.; Martinez, A.; Mondaca, M. A. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2008, 105, 327-32.
102. das Neves, J.; Pinto, E.; Amaral, M.; Bahia, M. Antifungal activity of a gel containing Thymus vulgaris essential oil against Candida species commonly involved in vulvovaginal candidosis. Pharm. Biol., 2009, 47, 151-3.
103. Hammer, K. A.; Carson, C. F.; Riley, T. V.; Nielsen, J. A review of the toxicity of Melaleuca alternifolia (tea-tree oil). Food Chem. Toxicol., 2006, 44, 616-25.
104. Lai, F.; Loy, G.; Manconi, M.; Manca, M. L.; Fadda, A. M. Artemisia arborescens L essential oil loaded beads: preparation and characterization. AAPS PharmSciTech., 2007, 8, E67.
105. Manou, I.; Bouillard, L.; Devleeschouwer, M. J.; Barel, A. O. Evaluation of the preservative properties of Thymus vulgaris essen tial oil in topically applied formulations under a challenge test. J. Appl. Microbiol., 1998, 84, 368-76.
106. Orafidiya, L. O.; Oyedele, A. O.; Shittu, A. O.; Elujoba, A. A. The formulation of an effective topical antibacterial product containing Ocimum gratissimum leaf essential oil. Int. J. Pharm., 2001, 224, 177-83.
107. Biju, S. S.; Ahuja, A.; Khar, R. K.; Chaudhry, R. Formulation and evaluation of an effective pH balanced topical antimicrobial product containing tea tree oil. Pharmazie, 2005, 60, 208-11.
108. Reichling, J.; Landvatter, U.; Wagner, H.; Kostka, K. H.; Schaefer, U. F. In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations. Eur. J. Pharm. Biopharm., 2006, 64, 222-8.
109. Valenta, C. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev., 2005, 57, 1692-712.
110. Lahlou, M. Methods to study the phytochemistry and bioactivity of essential oils. Phytother. Res., 2004, 18, 435-48.